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Abstract
Sleep behavior remains one of the most enigmatic areas of life. The unanswered questions range
from ‘‘why do we sleep?’’ to ‘‘how we can improve sleep in today’s society?’’ Identification of
mutations responsible for altered circadian regulation of human sleep lead to unique
opportunities for probing these territories. In this review, we summarize causative circadian
mutations found from familial genetic studies to date. We also describe how these mutations
mechanistically affect circadian function and lead to altered sleep behaviors, including shifted or
shortening of sleep patterns. In addition, we discuss how the investigation of mutations can not
only expand our understanding of the molecular mechanisms regulating the circadian clock and
sleep duration, but also bridge the pathways between clock/sleep and other human
physiological conditions and ailments such as metabolic regulation and migraine headaches.
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Introduction
Sleep is a fundamental biological phenomenon for most
organisms and humans spend, on average, a third to a fourth
of their lives in the state of sleep. The lack of sleep and
dysregulation of daily sleep rhythms have been linked to a
number of ailments and outcomes; cancer (Sahar & Sassone-
Corsi, 2009), type two diabetes (Huang et al., 2011),
metabolic syndrome (Wolk & Somers, 2007), cellular stress
(Hardeland et al., 2003) and most seriously, death (Montagna,
2005). Though great strides have been made in understanding
sleep by utilizing model organisms, the regulation of sleep
and the functional roles of sleep for humans remain mostly
unclear (Frank, 2006). The molecular benefits of sleep have
been linked to the pruning and reorganization of dendrites
(Benington & Frank, 2003; Maret et al., 2011), and to the
modification of gene expression for the synthesis of new
biomolecules and metabolites (Tononi & Cirelli, 2006).
Theories on the necessity of sleep range from the conserva-
tion of energy (Jung et al., 2011) to metabolic repair during
sleep (Bonnet & Arand, 1996).
The Earth rotates with a 24-h (circadian) cycle and this
dictates that many (if not all) of our physiological functions
are subject to circadian regulation (Dunlap, 1999). What we
have learnt from past studies is that our endogenous circadian
clock regulates many of our body functions including sleep
behavior. The most accepted model for describing sleep
behavior, the ‘‘Two Process Model’’, was proposed by
Borbe´ly in 1982; Process S represents sleep homeostasis
and process C represents circadian rhythm regulation
(Borbe´ly & Achermann, 1999). The ‘‘Two Process Model’’
postulates that the interaction between the sleep–wake-
dependent ‘‘process S’’ and the circadian ‘‘process C’’ can
explain essential aspects of sleep regulation. How both of
these processes are changed by human circadian mutations
will be discussed throughout this review. Research into the
identification of non-circadian genes that regulate sleep
homeostasis has been quite fruitful. These non-circadian
genes and regulatory networks have been detailed excellently
in the following reviews (Andretic et al., 2008; Crocker &
Sehgal, 2010; Sehgal & Mignot, 2011).
Investigation of human behavioral traits is inherently
challenging since we are known to modify our behaviors by
social, cultural and habitual factors. Regardless, the connec-
tion between genes and behavioral traits has been established
(Plomin et al., 2012). For humans, one of the most compelling
evidence for genetic influences on behavior came from the
studies done by Thomas Buchard and his colleagues at the
Minnesota Center of Twin and Family Research (Bouchard
et al., 1990). After decades of study, they concluded that there
are deep-seated psychological, behavioral and emotional traits
that are determined at birth. Hence, human genetics can be
used as a powerful tool to investigate human behaviors.
In addition, the wealth of knowledge and information that
have been accumulated in the past 20–30 years from studies
of model organisms, especially fruit flies (Hardin, 2011) and
mice (Lowrey & Takahashi, 2011), has augmented enor-
mously to the understanding of human sleep behaviors.
Contributions from these diverse fronts have significantly
improved our understanding on the regulatory mechanisms of
human sleep schedule in recent years which will be discussed
in this review.
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Human circadian sleep phenotypes
The majority of people go to bed from 10 pm to midnight and
gets up between 6–8 O’clock in the morning. There is a small
proportion of people who are either night owls (staying awake
until late into the night) or morning larks (demonstrating an
extreme early morning awakening) (Jones et al., 1999).
Besides environmental influences, rare genetic variants can
also directly shift sleep schedules. The first genetic form of
human sleep schedule behavior was reported in 1999 (familial
advanced sleep phase, FASP) (Jones et al., 1999). FASP
individuals demonstrate a forward shift in six different
measurements related to sleep (including sleep onset time,
sleep offset time, dim light melatonin onset time, core body
temperature, and rapid eye movement (REM) sleep onset
time) compared to control subjects. Since the discovery of this
rare genetic sleep trait, significant progress has been made in
our understanding of human circadian rhythm disorders with
the characterization of additional sleep phenotypes.
The International Classification of Sleep Disorders
includes approximately 60 disorders of human sleep, among
them are circadian rhythm sleep disorders (Medicine, n.d.).
Circadian rhythm sleep disorders usually exhibit as a social
problem in a person’s sleep/wake timing, though there are
many other sleep disorders demonstrating sleep dysfunction
with sleep at the ‘‘wrong times’’. Circadian rhythm sleep
disorders individuals suffer from difficulty initiating or
ending sleep at appropriate social times.
Circadian rhythm sleep disorders include the following
types according to the American Academy of Sleep Medicine
(AASM) (Sack et al., 2007a, b). Advanced sleep phase
disorder (ASPD) individuals have earlier sleep/wake times
than the average population and their entire sleep–wake cycle
is shifted forward several hours. ASPD people are described
as ‘‘morning larks’’ that demonstrate an extreme early
morning awakening before others are active. However, they
also have difficulty in staying awake to satisfy domestic
responsibilities in the evening, resulting in significant sleep
deprivation if social responsibilities keep them from staying
with their internal natural biological clock. It is worth noting,
ASPD is more commonly seen in the elderly (Sack et al.,
2007b). However, unless patients complain of a problem with
waking early, ASPD can be described only as advanced sleep
phase (ASP) or with a family history of familial advanced
sleep phase (FASP).
In contrast to ASPD, delayed sleep phase disorder (DSPD)
is marked by the opposite phenomena where the sleep–wake
cycle is shifted later, and DSPD patients feel wide awake,
energetic and motivated until late in the night. Although,
similar to ASPD, unless patients complain of a problem with
waking late, DSPD can be described only as delayed sleep
phase (DSP) or with a family history of familial delayed
sleep phase (FDSP). DSPD individuals often suffer from sleep
deprivation since their sleep onset is delayed by the biological
clock and morning waking time is dictated by the alarm clock
and social responsibilities. DSPD has an estimated prevalence
of 7%–16% in adolescents and young adults (Sack et al.,
2007a, b).
Another sleep phenotype is the free-running sleep disorder
(FRSD) where the sleep–wake cycle for these individuals is
shifted approximately 1 h later everyday. This disorder is
linked to retinal blindness and likely precipitates from the
lack of light resetting of the circadian clock (Sack, 2007a, b).
Finally, irregular sleep–wake disorder (ISWD) individuals
have an undefined sleep–wake cycle where sleep occurs
throughout the day. This is often seen in dementia patients
who are suffering from neurological dysfunction and can be
seen as well in mentally retarded patients. These individuals
also suffer from insomnia, as they are unable to experience
consolidated sleep (Sack, 2007a, b).
Mammalian molecular clock
Circadian rhythmicity was first noted in the observation that
leaf movements (opening and closing) followed a daily
rhythm even in the absence of sunlight (de Mairan, 1729). It is
now established that the circadian rhythms of human body
functions are regulated by an endogenous molecular clock.
The mammalian molecular clock is composed of a core set of
transcription factors that form functional regulatory feedback
loops (Brown et al., 2012; Mohawk et al., 2012; Takahashi
et al., 2008). The main feedback loop consists of Period (PER
1/2), Cryptochrome (CRY 1/2), Brain and muscle ARNT-like
1 (BMAL1) and Circadian locomotor output cycles kaput
(CLOCK) (Brown et al., 2012; Takahashi et al., 2008).
BMAL1 and CLOCK (or NPAS2, a paralog of CLOCK) form
a heterodimer and binds to the promoter element described as
an enhancer box (E-BOX) of PER and CRY. The transcription
and translation of PER and CRY increase protein levels in the
cytoplasm, whereby the two proteins then heterodimerize and
translocate into the nucleus. In the nucleus, the CRY/PER
heterodimer binds to BMAL1/CLOCK to repress transcrip-
tional activation, leading to the termination of their own
transcription (Figure 1). PER and CRY are subsequently
degraded through the proteasomal pathway, allowing for the
reactivation of transcription of PER and CRY by BMAL1/
CLOCK (Brown et al., 2012; Mohawk et al., 2012; Takahashi
et al., 2008) (Figure 1). This transcriptional/translational
negative feedback loop takes approximately 24 h to complete,
thus defining the circadian period, and denotes the proteins
involved in the circadian cycle as the ‘‘core clock’’
(Takahashi, 2004). The core circadian loop is further
regulated by post-translational regulation summarized later
in this review. Circadian regulators that make up additional
negative feedback loops or interlocking loops are: activators
RAR-related orphan receptor A (RORA), D site of albumin
promoter-binding protein (DBP), repressors nuclear receptor
subfamily 1, group D, member 1 (NR1D1/REV-ERB) and
basic helix-loop-helix family, members e40 and e41 (DEC1,
2 respectively). These activators and repressors act in a
circadian manner, providing additional stability and levels of
regulation (Ueda et al., 2005). The cycling of these factors
operates without requiring extrinsic feedback, and exists in
most cell types. Approximately 3%–10% of gene transcripts
oscillate in a circadian manner, whose subsets vary according
to cell type (Akhtar et al., 2002; Duffield et al., 2002; Hughes
et al., 2009; Miller et al., 2007; Panda et al., 2002; Storch
et al., 2002). The expression levels of many clock components
themselves also demonstrate oscillation. Interestingly, precise
rhythmicity of PER2 is necessary for driving cellular
466 W. C. Hallows et al. Crit Rev Biochem Mol Biol, 2013; 48(5): 465–475
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circadian oscillations, whereas oscillations of other core clock
components such as CRY1, CLOCK and BMAL1 are less
critical (Chen et al., 2009).
Post-translational modifications in molecular clock
Post-translational regulation gives the core clock its ability to
generate precisely tunable timing, since different post-trans-
lational modifications can mark the different circadian
proteins for different functions at different times over the
24-h clock. Utilizing post-translational modifications the
clock is directly tied to the cells’ intermediary metabolism,
linking the small molecule metabolites; ATP, Acetyl CoA,
NADþ, UDP-GlcNAc, to the core clock’s timing. For
instance, PER2 functions through heterodimerization with
CRY for its translocation and the suppression of CLOCK/
BMAL1 gene activation (Brown et al., 2012; Mohawk et al.,
2012; Takahashi et al., 2008), and this heterodimerization is
likely modulated by numerous post-translational modifica-
tions to ensure the correct and precise timing of transcrip-
tional inhibition. Post-translational modifications likely
regulate each of these steps during the cycle of PER2
allowing for the exact control of clock gene regulation and its
fine adjustment to outside stimulus. All in all, these various
regulatory pathways highlight the intricacy of post-transla-
tional regulatory mechanisms of the circadian clock.
Besides PER2, many other circadian clock proteins such as
CRY, BMAL1 and CLOCK have been identified as targets of
post-translational modifications (Gallego & Virshup, 2007).
In fact, an understanding of the importance of complex post-
translational modification in regulation of circadian rhythms
emerged in recent years. Post-translational modifications are
central to the hypothesis that circadian mutations affect sleep
schedules through a disruption or change of normal post-
translational modifications throughout the circadian period.
Here, we first review the known complex network of post-
translational modifications and later detail the mutations that
affect circadian rhythms through post-translational
alterations.
PER2 is the best example illustrating the complexity
of post-translational regulation for the molecular clock
(Gallego & Virshup, 2007; Vanselow & Kramer, 2007).
Phosphorylation has been identified on 21 of 247 serine or
threonine residues of mPER2 (Vanselow et al., 2006).
Although the mechanistic consequences for most of these
phosphorylation sites are unknown, it is hypothesized that
phosphorylation localized in the N-terminus of mPER2 can
lead to the stabilization and nuclear localization of the protein
by CKII (Maier et al., 2009). Also, phosphorylation in the
CKI domain increases the half-life of mPER2 (Shanware
et al., 2011; Vanselow et al., 2006; Xu et al., 2007). In
addition, as described later, the phosphorylation of PER2 at
one of the key serine residues (S662) can modulate the period
length (Xu et al., 2007). Other clock proteins such as BMAL1
and CRY are also regulated by phosphorylation. Specifically,
BMAL1 has been shown to be phosphorylated by c-Jun N-
Figure 1. Circadian clockwork. The core circadian clock is made up of two interlocking transcriptional and post-translationally regulated feedback
loops. BMAL1 and CLOCK heterodimerize to form an activating transcriptional complex that binds to the E-Box on the genes PER, CRY, ROR and
REV-ERB. The production of PER and CRY protein builds until PER and CRY are modified post-translationally and then heterodimerize and
translocate into the nuclei where they bind to CLOCK and BMAL1 and block the transcriptional activation of E-BOX specific targets. PER, CRY
and BMAL1 are degraded by proteasomes. In a second loop, BMAL1 transcription is activated and repressed by ROR and REV-ERB respectively by
binding to the RRE DNA element. (see colour version of this figure at www.informahealthcare.com/bmg).
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Cr
iti
ca
l R
ev
ie
w
s i
n 
Bi
oc
he
m
ist
ry
 a
nd
 M
ol
ec
ul
ar
 B
io
lo
gy
 D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
U
ni
ve
rs
ity
 o
f C
al
ifo
rn
ia
 S
an
 F
ra
nc
isc
o 
on
 1
2/
06
/1
3
Fo
r p
er
so
na
l u
se
 o
nl
y.
terminal kinase (JNK), and when BMAL1 is hypopho-
sphorylated due to JNK inhibition, the circadian period is
lengthened (Yoshitane et al., 2012). Furthermore, BMAL1 is
phosphorylated by Protein Kinase Cg (PKCg) in response to
the food entrainable oscillation. This phosphorylation stabil-
izes BMAL1 protein by reducing BMAL1 ubiquitination
(Zhang et al., 2012). CRY2 is regulated by phosphorylation in
a sequential pattern initiated by dual specificity tyrosine-
phosphorylation-regulated kinase 1 A (DYRK1A) at serine
557 then phosphorylation at serine 553 by glycogen synthase
kinase 3b (GSK-3b) leading to CRY2 degradation
(Kurabayashi et al., 2010). Conversely, CRY1 is regulated
in the liver by adenosine monophosphate-activated protein
kinase (AMPK)-mediated phosphorylation leading to CRY1
depletion from the nucleus (Lamia et al., 2009).
Acetylation has gained recent notoriety as another post-
translational modification that regulates cellular protein
functions (Haigis & Sinclair, 2010; Peng & Seto, 2011). In
particular, acetylation and the subsequent deacetylation by
Sirtuin-1 (SIRT1) are also implicated in the regulation and
degradation of PER2 (Asher et al., 2008). Although the
specific residues for acetylation of PER2 and how acetylation
affects PER2 biophysically are unknown, SIRT1-mediated
deacetylation promotes the degradation of PER2, and loss of
SIRT1 increases PER2 protein stability (Asher et al., 2008).
Similarly, BMAL1 is regulated by reversible acetylation,
specifically acetylated at lysine 537 by the acetyltransferase
activity of CLOCK, and deacetylated by SIRT1 (Nakahata
et al., 2008). Acetylation of BMAL1 confers circadian timing
of BMAL1 by metabolite sensing through nicotinamide
adenine dinucleotide (NADþ) (Ramsey et al., 2009).
Moreover, post-translational O-linked N-acetylglucosa-
mine modification (O-GlcNAcylation) has recently been
shown to exhibit regulatory effects on the circadian clock.
O-GlcNAcylation in the heart exhibits diurnal oscillation,
which is regulated by glucose, O-GlcNAc transferase (OGT)
and O-GlcNAc hydrolase (OGA) levels (Durgan et al., 2011).
OGA levels and OGT activities in turn oscillate with daily
rhythms. On the other hand, O-GlcNAcylation levels can
modulate the clock speed. Higher O-GlcNAcylation leads to
longer circadian period and lower O-GlcNAcylation
shortens the period (Kaasik et al., 2013; Kim et al., 2012).
Like phosphorylation, O-GlcNAcylation regulates the
molecular clock through various pathways including modifi-
cation of transcriptional factor activities, nuclear translocation
of clock proteins, and ubiquitin-mediated targeting for deg-
radation of clock proteins (Kaasik et al., 2013; Kim et al.,
2012; Li et al., 2013).
Other known post-translational modifications include
ADP ribosylation on CLOCK (Asher et al., 2010), sumoyla-
tion on BMAL1 (Cardone et al., 2005; Lee et al., 2008), and
ubiquitination on CRY (Hirano et al., 2013; Yoo et al., 2013)
and BMAL1 (Zhang et al., 2012). Poly ADP-ribosylation of
CLOCK enhances CLOCK/BMAL1 complex binding to
DNA by poly(ADP-ribose) polymerase 1 (PARP-1) activity
initiated in the early light phase of circadian time.
Sumoylation of BMAL1 occurs in the liver and promotes
the circadian transcriptional activation of the CLOCK/
BMAL1 complex on DNA. This activation occurs in
combination with ubiquitination of BMAL1, requiring co-
modification for activation. Finally, CRY is ubiquitinated by
FBXL21 and FBXL3, F-box-type ubiquitin E3 ligases. These
E3 ligases work in the nucleus and cytoplasm, respectively, to
activate and time CRY activity for the suppression of
circadian gene activation with PER by targeting CRY for
proteasomal degradation (Hirano et al., 2013; Yoo et al.,
2013).
Mutations causing human circadian phenotypes
Familial advanced sleep phase
PER2-S662G
To determine the genetic basis of FASP, linkage analysis was
performed in a large family segregating the FASP trait. The
mutation was determined to be on chromosome 2, and further
analysis identified PER2 as the gene containing the mutation.
In the hPER2 cDNA, position 2106 was changed from A to G
which causes the substitution of a serine at amino acid 662
with a glycine (S662G) (Toh et al., 2001). The mutation is
localized in the CKI binding domain of PER2, and as the
mutation substituted a glycine for a serine residue, the
hypothesis that the mutation affected the phosphorylation of
PER2 was tested. Initial testing suggested that the mutation of
PER2 at Ser662 reduced CKIe phosphorylation (Toh et al.,
2001); later data suggested that mutation at Ser662 disrupts
the phosphorylation of CKId in vitro (Xu et al., 2007).
Because the mutant PER2 protein demonstrated reduced
phosphorylation by CKId, the functional consequence of a
reduction of PER2 phosphorylation in vivo was tested (Xu
et al., 2007). BAC transgenic mice carrying this human
mutation were generated and then tested in a circadian
behavioral assay. These mice recapitulate the human FASP
phenotype, including both advanced sleep phase and a
shortening of behavioral and cellular circadian period length
(Xu et al., 2007). These observed phenotypes are associated
with enhanced transcriptional repression, as mRNA levels of
both the endogenous copy of mouse Per2 and the introduced
human copy of PER2 decreased. The change in repressor
activity is caused by a disruption of phosphorylation at
Ser662, which normally results in a phosphorylation cascade
of four downstream serine sites. Hence, through a still
unknown mechanism, the lack of phosphorylation allows
PER2 to act as a stronger repressor. Supporting this mech-
anism, a second transgenic mouse model with a substitution
of the Ser662 to aspartic acid (which mimics constitutive
phosphorylation) resulted in a lengthened circadian period
and decreased repressor activity demonstrated by protein and
RNA analysis. In vitro evidence also suggests that mutation of
PER2 at S662G enhances PER2 clearance from the nuclei
(Vanselow et al., 2006). While enhancing repressor activity
would naturally decrease expression levels, another concur-
rent possibility for protein reduction presented by Vanselow
and colleagues is that the changes in PER2 phosphorylation
results in deficient nuclear retention, which then promotes
PER2 degradation in the cytoplasm (Vanselow et al., 2006).
In the future, it will be necessary to investigate the function
of phosphorylation in the CKI domain. Phosphorylation of
PER2 has so far been linked to the protein half-life, the ability
to interact with other proteins and subcellular localization.
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Specifically, it is important to investigate how phosphoryl-
ation sites work in tandem or in opposition of one another to
unravel the mystery of circadian cycling and sleep timing.
CKI-T44A
Since the initial identification of a mutation that causes FASP,
additional families were identified to have FASP but did not
contain the previously identified mutation in PER2. Utilizing
a candidate gene approach, a causative mutation for a second
FASP family was identified in human CKId (Xu et al., 2005).
The mutation occurs at Threonine 44 and is substituted with
alanine (T44A). This particular amino acid was conserved in
the CKI family of proteins in mouse and human as well as in
the Drosophila melanogaster CKI homolog Doubletime
(homolog of CKId and CKIe). Biochemical assays displayed
mutation-induced decreases in phosphorylation of alpha-
casein, and PER protein substrates by in vitro kinase assays
strongly suggesting biological relevance for this genetic
variant. To validate the mutated function of CKId, a BAC
transgenic mouse model carrying CKI-T44A was generated.
These mice were tested in wheel-running behavioral assays to
determine the functional consequence of the mutant kinase,
and their free running period () was shorter than control
mice by 20 min. When the mutant transgenic mice were
crossed with CKI knock-out mice, an even shorter  was
observed (22.7 h versus 23.4 h) in addition to rescuing the
lethal phenotype of the CKI knock-out (the mutation does
not render the kinase activity null). Intriguingly, expressing
the human CKI-T44A mutation in Drosophila generated flies
with a significantly longer period than control flies, which
highlighted the underlying differences between mammals and
invertebrates (Xu et al., 2005).
To address the mechanism of reduced kinase activity, the
crystal structure of the mouse homolog CKId was analyzed to
better understand the functional consequence of the mutating
threonine to alanine (Figure 2). The mutation occurs in the
loop between the beta sheets that make up the ATP binding
domain in the catalytic domain of CKId. Specifically, the loss
of threonine and replacement with a hydrophobic amino acid
(alanine) may cause misfolding or loss of flexibility of the
loop, which then restricts the enzyme (Figure 2). Because the
mutation causes a reduction of catalytic activity, it is possible
that the mutation causes a disruption in chemical catalysis of
phosphate transfer from ATP, through restriction of the
enzyme’s flexibility.
CKI H46R
After identifying CKI-T44A, the gene encoding CKId in
blood samples from over 70 FASP probands were screened,
and a second mutation was identified in a single individual
that predicted a histidine to arginine change at position 46
(H46R), two amino acids downstream from the T44A
substitution (Brennan et al., 2013). Neither T44A nor H46R
is present in the 1000 Genomes database and the publicly
available CGI 60 Genomes database (1000 Genomes Project
Consortium et al., 2012; Drmanac et al., 2010).
As previously discussed, CKId-T44A has reduced kinase
activity in comparison to wild type (WT) enzyme. Utilizing a
CKId-H46R isoform, the kinetics of phosphotransfer was
analyzed. CKId-H46R similarly showed decreased kinase
activity on alpha casein and the PER2 peptide (Brennan et al.,
2013). The decrease in Vmax suggests that the mutation causes
a reduction in the catalytic rate of phosphotransfer. There may
be a subtle effect on enzyme recognition of the substrate as
the Km of the mutant kinase activity is decreased with PER2
peptide but is not significantly different for casein or ATP.
Utilizing molecular modeling, we hypothesize that the
reduction of activity can be attributed to the loss of the
hydrogen bond that forms between H46 and the glutamine
residue at amino acid 48 (Figure 3). Though the function of
the hydrogen bond is unknown, it may be to properly fold the
loop during catalysis. It is also unclear what the structural
consequence of the mutant arginine has on the tertiary
structure. However, it is reasonable to hypothesize that the
structural integrity in this region is important for the catalytic
function of the phosphotransfer.
Further work is needed to identify the structural ramifi-
cations of the H46R and the T44A mutations, which will give
Figure 2. Molecular modeling of T44A mutation. Utilizing PyMOL, the structure of the human CKId with the mutation T44A was modeled from rat
CKI (1CKI). The replacement of threonine with the hydrophobic amino acid alanine may cause protein misfolding or loss of flexibility of the loop,
which then restricts the enzyme, likely lowering enzymatic activity. (see colour version of this figure at www.informahealthcare.com/bmg).
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insight to the structural function of the loops on CKId. It will
also be interesting to reveal other possible cellular ramifica-
tions of mutating a kinase integral to the Wnt signaling
pathway. The function and mechanism of CK1d phosphoryla-
tion may illuminate the role phosphorylation plays in
migraine headache (Brennan et al., 2013).
Mutation altering human sleep duration
Familial natural short sleep
A family was found to display natural short-sleep phenotype
characterized by the reduction of sleep time and increased
daily activity, described as familial natural short sleep
(FNSS). Subsequently, a point mutation that changed the
amino acid at position 384 from proline to arginine (P384R)
in DEC2 was identified (He et al., 2009). This mutation
co-segregates with the FNSS phenotype in this family.
DEC2 is a negative component of the circadian clock (Butler
et al., 2004). It belongs to a basic helix-loop-helix (bHLH)
protein family in which members can homodimerize and can
affect gene transcription by direct binding to DNA
(Fujimoto et al., 2001, 2007). P384 is localized in the C-
terminal proline-rich domain and its flanking sequences are
highly conserved among mammalian DEC2 orthologs.
DEC2-P384R mutation alleviated its transcriptional repres-
sive activity demonstrated by in vitro luciferase reporter
assay. BAC transgenic mice carrying this P384R mutation
exhibited a shorter total sleep time and longer active time
per 24-h period as seen in human mutation carriers. This
result was further verified by electroencephalography (EEG)
and electromyography (EMG) performed on DEC2-P384R
mutant transgenic mice and their littermates. In addition to
transgenic mice, transgenic flies carrying the P384R muta-
tion were generated to test whether Drosophila melanogaster
would demonstrate a conserved phenomenon with humans
and mice. Transgenic flies with mutant Dec2 expressed in
their mushroom bodies showed a similar lengthened active
duration behavior, suggesting DEC2 plays a significant role
in regulating sleep quantity.
The DEC2 mutation is hypothesized to vary sleep quantity
by altering the structure of the protein. The mutation of DEC2
incorporates an arginine residue in place of a proline, which
can incorporate a locked turn in the protein by the nature of
the proline structure. The replacement of the proline with
arginine introduces a charged amino acid with the guanidino
group of the arginine. In addition, the amino acid substitution
is in the glycine and alanine-rich region of the DEC2 protein
that has been shown to interact with HDAC1, the protein
deacetylase and a known regulator of transcription factors
(Fujimoto et al., 2007) (Figure 4). Hence, the mutation may
interrupt the interaction between HDAC1 and DEC2, and lead
to altered gene transcription, by altering the acetylation status
of DEC2 or by affecting HDAC1-dependent deacetylation of
other transcription factors. Future work to elucidate the
molecular mechanisms of DEC2 on sleep length regulation
includes identifying genes that are regulated by DEC2, and
specifically how the FNSS mutation affects gene transcription
and protein function.
Insight from murine circadian mutations
The initial insight into how circadian rhythm genes
affect sleep function was revealed by the tau mutant Syrian
hamster (Ralph & Menaker, 1988). This mutation conferred a
Figure 3. Molecular modeling of H46R mutation. Utilizing PyMOL, the structure of the human CKId with the mutation H46R was modeled from rat
CKI (1CKI). The replacement of histidine with the larger guanidino containing amino acid arginine may cause protein misfolding or loss of flexibility
of the loop. Specifically as shown, there is an increased distance between the hydrogen bonding of the mutant arginine with glutamine at position 48,
which then restricts the enzyme, likely lowering enzymatic activity. (see colour version of this figure at www.informahealthcare.com/bmg).
Figure 4. DEC2 interacting domains with HDAC. DEC 2 contains most
notably a basic helix-loop-helix domain that has been shown to interact
with SIRT1, which may play a significant role in DNA binding
regulation. By homology, there is an orange domain. HDAC1 interacts
with the Ala/Gly rich region of DEC2, interestingly where the P384R
mutation resides. The mutation may disrupt or promote HDAC1
interaction and may be the key to understanding the molecular
mechanism of DEC2 regulation of NSS. (see colour version of this
figure at www.informahealthcare.com/bmg).
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free-running time in the mutant animals to that of 22 h instead
of the wild type 23.5 h. Further characterization of the
mutation mapped it to a single nucleotide change in the gene
encoding the enzyme CKI". This mutation has been examined
in vitro and hypothesized to decrease enzymatic activity in the
general enzyme, but has also been hypothesized to have
increased specificity or gain-of-function for PER by increas-
ing PER2 degradation (Lowrey et al., 2000). Interestingly, tau
and the mutation in human CKId give a similar shortened
period, though the mechanisms seem to differ as far as the site
and the function of the mutation (gain-of-function versus loss)
(Xu et al., 2005). Albeit the exact molecular mechanism of
CKId regulation needs to be further explored, this reinforces
the idea that phosphorylation can have many different effects
on a single protein that later can result in the same phenotype.
Another mutation affecting mouse circadian function was
identified using a forward genetics screen. Mice were treated
with N-ethyl-N-nitrosourea (ENU), and then subjected to
free-running activity measurements. Using this method, a
semi-dominant mutation was identified in the CLOCK gene
(King et al., 1997). This mutation deletes exon 19, which
interrupts the bHLH-PAS domain and likely blocks transcrip-
tional regulation of CLOCK. Although to date no human
mutations in the CLOCK gene have been identified, mutations
in CLOCK could possibly cause the ‘‘night owl’’ phenotype
of FDSP by delaying the clock as seen in the mice.
Two mutations, cysteine 358 to serine (Godinho et al.,
2007) and isoleucine 364 to threonine (Siepka et al., 2007), in
F-box protein 3 (FBXL3) were found independently using
ENU mutagenesis. Both mutations lead to long free-running
period by affecting the expression of PERs and the stabiliza-
tion of CRYs. Finally, a new mutation was recently identified
in another F-box protein, FBXL21, an E3 ubiquitin ligase
specific to CRY1 in the mouse (Yoo et al., 2013). The
mutation in FBXL21 conferred a change of amino acid 149
from a glycine to a glutamine. Interestingly, this mutation
leads to period shortening and antagonizes the period
lengthening effect of the FBXL3 isoleucine 364 threonine
mutation. FBXL21 was found to stabilize CRYs and antag-
onize the destabilizing action of FBXL3 on CRYs (Hirano
et al., 2013). The FBXL21-G149E mutation reduces the
protective effect of FBXL21. These mutations again point out
the importance of post-translational modifications in the
precise timing and function of the core circadian oscillators.
It is not unreasonable to predict that human FBXL21/3
homologs will play similar roles in regulating human sleep
behaviors, highlighting the importance of studying model
organisms for understanding human circadian regulatory
mechanisms.
How do human circadian mutations help us under-
stand the regulation of human circadian clock and
sleep behaviors/beyond finding the mutations?
PER2
The PER2-S662G mutation for FASP was found in the
CKI binding region. This region of the PER2 protein is
highly conserved among mammalian PERs, and there
are four additional serines immediately C-terminal to
the mutated serine at amino acid 662 (Xu et al., 2007).
In vitro biochemical studies showed that the serine at 662
needs to be phosphorylated by a priming kinase which is
followed by phosphorylation of four additional serines by
CKId (Xu et al., 2007). Transgenic mice that carry the S662G
mutation showed a shorter circadian period (22 h) than WT
control mice (23.7 h) (Xu et al., 2007). Intriguingly, trans-
genic mice that carry a serine to aspartic acid change (to
mimic a constitutively phosphorylated serine) have a longer
period (24.5 h). When serine 662 is phosphorylated, it allows
the four additional serines to be phosphorylated; therefore all
five serines are phosphorylated. This then leads to weaker
repression by PER2 (described above) and animals have a
longer period (analogous to a slower clock because it will take
longer to finish a cycle). However, when residue S662G
cannot be phosphorylated in vitro, the next four serines are
not phosphorylated by CKId. Then the PER2 protein is a
stronger repressor and animals have a shorter period (similar
to having a faster clock) (Xu et al., 2007). Studies also
revealed that the hypophosphorylated PER2 is less stable and
the hyperphosphorylated protein is more stable. Collectively,
these results imply that PER2 acts as a circadian repressor and
that when S662 phosphorylation is blocked, it adopts a
conformation so that it becomes a stronger repressor and is
less stable. However, when all five serines in the specific
region are phosphorylated, the protein adopts a different
conformation, which renders it a weaker repressor and more
stable. Therefore, the suicide model for transcriptional factors
(Fu, 2008) can be applied to describe PER2 (and potentially
other transcription factors of the molecular clock) and offers a
possible mechanism linking the transcription repressor activ-
ity to its own degradation.
Because the four serines immediately C-terminal to S662
are likely phosphorylated by CKId, mouse models were used
to test the genetic interactions between CKId and PER2. The
copy number of CKI does not affect the period length of WT
mice. However, when PER2-S662G mice were crossed with
CKI heterozygous knockout mice, the period was longer
(22.33 h) than S662G transgenic mice. In addition, when
PER2-S662G mice were crossed with WT CKI transgenic
mice (carrying four to five copies of CKI), the period was
shorter (20.83 h) than S662G mice (Xu et al., 2007). These
results revealed that there are other sites on PER2 that can be
phosphorylated by CKId; and when these other sites are
phosphorylated, it leads to shorter period (Xu et al., 2007).
Therefore, there are multiple sites for CKId action on PER2.
One of them is the S662 region and when this site is fully
phosphorylated, it leads to increased PER2 mRNA and
protein levels and a longer period. However, there are other
sites on PER2 that when phosphorylated by CKId, leads to
increased protein degradation, lower protein levels, and a
shorter period. Under normal conditions, phosphorylation of
different regions maintains a balance, leading to a stable
period length. For CKI heterozygous knockout, there is lower
CKId level but it affects both pathways to a similar extent, so
period stays the same. Similarly, for WT transgenic mice, the
higher CKId level will affect both pathways to the same extent
and period therefore is unchanged (Xu et al., 2007). For
PER2-S662G mutant mice, the pathway for S662 is blocked
which then pushes the balance towards the other side and
leads to shorter period length (Figure 5). When PER2-S662G
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is crossed onto CKI-WT transgene mice, the higher CKId
level will push the balance towards the other side even more
and produces an even shorter period (20.83 h) (Xu et al.,
2007). When S662G mice is crossed with CKI heterozygous
knockout, the reduced CKId level will decrease the phos-
phorylation unbalance and therefore gives a less short period
of 22.33 h. Overall, these data point out the importance of
PER2 phosphorylation in setting the speed of the clock.
Further complicating the molecular scenario, PER2 is
O-GlcNAc modified and O-GlcNAcylation further enhances
PER2 repressor activity (Kaasik et al., 2013). OGT
(O-GlcNAc transferase) does not affect PER2-S662G repres-
sor activity, suggesting that S662 site may be competitively
regulated by phosphorylation and O-GlcNAcylation.
Interestingly, S662, S668 and S671 of the 5-serine region in
PER2 are all O-GlcNAcylation sites. O-GlcNAcylation is
dependent on the level of UDP-GlcNAc substrate, and UDP-
GlcNAc synthesis is dependent on nutrient fluxes including
glucose (Hart, 2013). Under low glucose condition, the PER2-
S662-S674 region is phosphorylated in the presence of CKId
even with OGT and OGA (O-GlcNAcase). However, under
conditions of high glucose, phosphorylation in this region is
reduced by the presence of OGT or OGA even with the
overexpression of CKId (Kaasik et al., 2013). As described
above, when the first serine is phosphorylated in this 5-serine
region, the four subsequent serines are phosphorylated.
This then leads to a weaker repressor with longer period.
But, phosphorylation in this region is also modulated by
O-GlcNAcylation, and under high glucose condition, phos-
phorylation in this region is blocked by O-GlcNAcylation that
then likely leads to a shortened period. Future in vivo
investigation will shed light on how sugar can modulate clock
speed and further our understanding of the connection
between circadian clock and metabolic regulation.
CKI
One interesting observation for the CKI-T44A mutation from
the very beginning was that human mutation carriers not only
have the FASP phenotype but also have asthma and migraine
headache (Brennan et al., 2013). One possible explanation for
this observation is that the kinase mutation could potentially
Figure 5. Mechanism of PER2 FASP. Under normal conditions, PER2 is phosphorylated by a specific kinase at the serine 662. This initial
phosphorylation ‘‘primes’’ the CKI domain for the subsequent recognition by CKId and the phosphorylation of the remaining serine residues
S665–S674. The phosphorylation of these residues renders PER2 a weaker repressor and confers a longer period length. Additional phosphorylation
site(s) on PER2 by CKId increases PER2 degradation and leads to a shorter period. Conversely, in the mutant BAC transgenic animal carrying S662G,
the priming kinase cannot recognize or phosphorylate the S662 residue, leaving the protein in the hypophosphorylated state; the lack of priming
prevents CKId from recognizing S665–S674. However, phosphorylation by CKI on the other site(s) of PER2 is unperturbed and degradation of PER2
continues without counter balance from the S662–S674 region. This then causes a shortened period and advancement of sleep phase. (see colour
version of this figure at www.informahealthcare.com/bmg).
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affect multiple substrates, therefore leading to multiple
phenotypes. To gain further insight into this observation, a
circadian phosphor-proteomic investigation was initiated for
CKId (Kategaya et al., 2012). In addition, a parallel study was
carried out for CKIe as comparison and control. Intriguingly,
CKId and e share some substrates/interacting partners, but
also each have their own subset of unique substrates/
interacting partners. One significant revelation from this
circadian phosphor-proteomic study is that CKId and e both
demonstrate interactions with different proteins at different
circadian times, pointing out the importance of considering
timing while studying kinases, substrates and the pathways in
which they are involved (Kategaya et al., 2012).
Because human mutation carriers in families with CKId
mutations (T44A and H46R) both experience migraine
headaches, the transgenic mouse model of T44A was used
to investigate the possibility of migraine phenotype. CKI-
T44A mice showed increased sensitivity to a migraine trigger
(nitroglycerin), which induced peripheral mechanical and
thermal hyperalgesia (Brennan et al., 2013). Migraine-related
cortical excitability was examined by measuring cortical
spreading depression (CSD) using optical imaging and
electrophysiological recording. CKI-T44A mice had signifi-
cantly lower CSD thresholds with increased number of CSD
elicited by stimulation, and their cortical surface arteries were
more dilated in all phases of CSD than control mice. In
addition, astrocytes from CKI-T44A mice demonstrated both
increased spontaneous and evoked calcium signaling than
astrocytes of control mice, suggesting possible astrocytic
mechanisms for CKId mutations to predispose carriers to
migraine. Migraine is common in the general population
(12%) and both genetic and environmental factors have been
implicated in contributing to this phenotype (Brennan et al.,
2013). The association between migraine and two independ-
ent CKId mutations, together with the in vitro and in vivo
data, suggests that these mutations contribute to the patho-
genesis of migraine. Though the relationship between sleep
regulation and migraine is unclear, all in all, these studies
revealed that CKId plays a diverse yet important role in
regulating brain excitability.
Model organisms
Investigating human phenotypes usually has an end goal of
understanding their underlying fundamental molecular mech-
anisms. The approach of finding the mutation and gene in
human subjects followed by generating a model animal for
further investigation has the advantage of studying a single
important gene, which can lead to the most relevant pathways.
One critical and powerful feature for studying human
conditions, whether in health or disease, is the fact that
humans can communicate with researchers about their
emotional and mental status. However, the major disadvan-
tage lies in the obvious impossibility of using humans in most
experimental procedures. For this reason, model organisms
are necessary research tools in pursuing these investigations.
On the other hand, not all mutations found in humans will
give equivalent (or at times any) phenotypes in model
organisms. To establish a ‘‘good’’ or ‘‘excellent’’ model
for studying human conditions requires extensive
characterization and comparison between the model and
human subjects. This also presents challenges since not all
comparisons are feasible. With behavioral phenotypes, this
challenge is especially augmented and needs additional
validations with extra attention from the researchers. To
date, the preferred method is to generate transgenic mice that
carry human mutations in order to study sleep behavior
phenotypes. Mice have the advantage of having closer brain
anatomy with humans, and also it is possible to measure EEG
for sleep stages in mice. Hence, this model organism has
recapitulated the human phenotype beautifully for many
mutations as described above. However, there are mutations
(or perhaps extremely rare polymorphisms) that were found in
humans, but no obvious phenotype could be found in
transgenic mice that carry the same mutations (Ptacek &
Fu, unpublished results). In addition, by their very nature,
mice are nocturnal and display a sleep–wake cycle directly
opposite to that of humans. This is further compounded by the
animal’s natural instinct to mask to light, making sleep and
activity measurements at times difficult to interpret
(Mrosovsky, 1999). Drosophila also has been used to model
human sleep behavior by generating transgenic flies carry
human mutations, and in some cases the phenotypes are
similar, yet other times different (He et al., 2009; Xu et al.,
2005). This further highlights the complexity of choosing the
‘‘right’’ model to assist in unraveling molecular mechanisms
involved in regulating human behavioral traits. Yet,
Drosophila is a uniquely malleable model organism that
researchers can utilize to investigate the possible mechanisms
that may shed significant and novel insight as well.
Concluding remarks
The diverse nature of sleep dysfunction and the lack of
treatments for many of these conditions accent the potential
for a wealth of research and medical opportunities. The
fundamental question of how our bodies integrate all infor-
mation (from environment and internal cues) and then
manifests them as certain sleep behaviors remains largely
unclear. The search for mutations by directed genetic screens
will likely identify numerous new mechanisms and pathways
previously thought unrelated to sleep and further enhance our
understanding of sleep. In depth studies of these mutations,
genes and pathways will reveal novel mechanisms that link
sleep to other phenotypes such as obesity, diabetes, mood
disorders, cancer and other seemingly unrelated physiological
processes. These investigations also underlie the importance
of combining the fields of biochemistry, genetics, cellular/
molecular biology and bioinformatics. The complex pheno-
type of sleep requires behavioral models in which experi-
mentation can describe the phenotype that can be
mechanistically investigated in vitro and in cells. Integrating
these interdisciplinary approaches will exponentially increase
the possibility of revealing the interwoven nature of human
sleep mechanisms that will improve the lives of people in
everyday society.
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